Boston Scientific (BSX) Income from Non-Controlling Interests (2023 - 2026)

Boston Scientific (BSX) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Income from Non-Controlling Interests changed 0.0% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 million (up 25.0% YoY), and the FY2025 full-year result was -$6.0 million, up 25.0% from the prior year.
• Income from Non-Controlling Interests steadied at -$2.0 million in Q1 2026, from -$2.0 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of -$1.0 million in Q4 2023 to a low of -$4.0 million in Q4 2024.
• A 4-year average of -$2.0 million and a median of -$2.0 million in 2024 frame the typical range for Income from Non-Controlling Interests.
• Across the five-year window, Income from Non-Controlling Interests slumped 300.0% in 2024 and jumped 50.0% in 2025, its largest moves.
• Tracing BSX's Income from Non-Controlling Interests over 4 years: stood at -$1.0 million in 2023, then tumbled by 300.0% to -$4.0 million in 2024, then jumped by 50.0% to -$2.0 million in 2025, then changed by 0.0% to -$2.0 million in 2026.
• Business Quant data shows BSX's Income from Non-Controlling Interests at -$2.0 million in Q1 2026, -$2.0 million in Q4 2025, and -$2.0 million in Q2 2025.